EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report

Anna Sällfors Holmqvist iD, Qingrui Meng, Wendy Landier iD, Lindsey Hageman, Liton F Francisco iD, Elizabeth Schlichting Ross, Nora Balas iD, Alysia Bosworth iD, Hok Sreng Te, Ravi Bhatia, F Lennie Wong iD, Daniel Weisdorf iD und 2 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Anna Sällfors Holmqvist und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Childhood Cancer Center, Skåne University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Bone Marrow Transplantation, Neoplasms, Second Primary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Childhood Cancer Fund, Leukemia Lymphoma Society, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human papillomavirus (HPV) is associated with an increased risk for a variety of squamous cell carcinomas in the general population. The risk for subsequent squamous cell carcinomas in blood or marrow transplantation survivors that are potentially related to HPV (cervical, oropharyngeal, vulvar, vaginal, anal, and penile cancer; HPV-related squamous cell carcinomas) remains unknown.

Methods

We determined the risk of HPV-related squamous cell carcinomas in 7936 2-year survivors of autologous or allogeneic blood or marrow transplantation performed between 1974 and 2014 and identified the role of demographic and clinical factors associated with HPV-related squamous cell carcinomas using proportional subdistribution hazards model for competing risks. Standardized incidence ratio was used to compare the risk of HPV-related squamous cell carcinoma with age-, sex-, and calendar-specific incidence in the general population.

Results

The median age at transplantation was 46 years (range = 0-78 years); 58.5% (n = 4642) were male, and 72.2% (n = 5727) were non-Hispanic White. Half (50.3%, n = 3991) of the patients had received an allogeneic blood or marrow transplantation. The standardized incidence ratio for oropharyngeal squamous cell carcinomas (n = 53) was 1.8 (95% confidence interval [CI] = 1.3 to 2.3) and for cervical squamous cell carcinoma among female blood or marrow transplantation recipients (n = 26) was 9.4 (95% CI = 6.3 to 13.6) compared with the general US population. The hazard of an HPV-related squamous cell carcinoma was higher among allogeneic blood or marrow transplantation recipients with chronic graft vs host disease (any HPV-related squamous cell carcinoma: HR = 6.24, 95% CI = 3.11 to 12.50; oropharyngeal: HR = 4.85, 95% CI = 2.11 to 11.15; cervical: HR = 4.98, 95% CI = 1.65 to 15.00; reference: autologous blood or marrow transplantation). Pre-blood or marrow transplantation radiation increased the risk of oropharyngeal squamous cell carcinoma (HR = 2.98, 95% CI = 1.57 to 5.65).

Conclusion

These findings underscore the importance of risk-based HPV vaccination and surveillance after blood or marrow transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellPapillomavirus InfectionsBone Marrow TransplantationNeoplasms, Second PrimaryHumansMaleFemaleMiddle AgedAdultAgedAdolescentYoung AdultIncidenceChildChild, PreschoolInfantPapillomaviridaeRisk FactorsHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, Childhood Cancer Center, Skåne University Hospital, Lund, Sweden.
  • Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, United States.
  • Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL 35233, United States.
  • Population Sciences, City of Hope, Duarte, CA 91919, United States.
  • Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, United States.
  • Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL 35233, United States.

ORCID-Profile: Anna Sällfors Holmqvist, Wendy Landier, Liton F Francisco, Nora Balas, Alysia Bosworth, F Lennie Wong, Daniel Weisdorf, Saro H Armenian, Smita Bhatia

Förderung

  • Swedish Childhood Cancer Fund
  • Leukemia Lymphoma Society
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Holmqvist, A. S., Meng, Q., Landier, W., Hageman, L., Francisco, L. F., Ross, E. S., Balas, N., Bosworth, A., Te, H. S., Bhatia, R., Wong, F. L., Weisdorf, D., Armenian, S. H., & Bhatia, S. (2025). Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf021

Vancouver

Holmqvist AS, Meng Q, Landier W, Hageman L, Francisco LF, Ross ES, et al. Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf021

BibTeX
@article{Holmqvist2025,
  author = {Holmqvist, Anna Sällfors and Meng, Qingrui and Landier, Wendy and Hageman, Lindsey and Francisco, Liton F and Ross, Elizabeth Schlichting and Balas, Nora and Bosworth, Alysia and Te, Hok Sreng and Bhatia, Ravi and Wong, F Lennie and Weisdorf, Daniel and Armenian, Saro H and Bhatia, Smita},
  title = {Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf021}
}
Kostenlos starten →